Priyavrat Bhartia

#407

Managing Director

Jubilant Pharmo·Healthcare

Age

22y

Exp

20y

Tenure

5/10

Risk

PragmaticDynastyFounderMid Cap

🎓 Bachelor's in Economics · Dartmouth College, USA

📜 MBA · Stanford University, USA

🏛️ Global-Elite

Wikipedia Company NSE

CompensationTBP

Personality

Open

Cons

Extr

Agre

Neur

Jubilant Pharmo

Healthcare · Mid Cap

Distressed / Turnaround · Hierarchical

About

Priyavrat Bhartia is the Managing Director of Jubilant Pharmo, a Mid Cap company in the Healthcare sector with a market cap of ₹13K Cr. A Pragmatic leader with 22 years of experience, he is known for consensus-driven decision-making and organic builder strategy. Focuses on steady value creation through complex regulatory environments with a preference for disciplined operational management.

FAQ

What is Priyavrat Bhartia's leadership style?

Priyavrat Bhartia is classified as a Pragmatic leader. He is consensus-driven in decision-making, with a dynasty builder motivation and steady-marathon pace of execution.

What is Priyavrat Bhartia's educational background?

Priyavrat Bhartia holds a Bachelor's in Economics from Dartmouth College, USA and a MBA from Stanford University, USA.

Who is the CEO of Jubilant Pharmo?

Priyavrat Bhartia is the Managing Director of Jubilant Pharmo. He has been with the company for 20 years and in the current role for 5 years.

Leadership DNA

ArchetypePragmatic

MotivationDynasty Builder

CrisisRestructurer

DecisionConsensus-Driven

GrowthOrganic Builder

PeopleRelationship Led

InnovationFast-Follower

PaceSteady-Marathon

PurposeProfit-Pure

CustomerB2B-Enterprise

EmployerSteady Employer

BrandTechnical-Expert

FocusOperational Excellence

OrientationDeep Specialist

Leadership Evidence

“Focuses on steady value creation through complex regulatory environments with a preference for disciplined operational management.”

⚡ Crisis●●●●○

Priyavrat Bhartia oversaw the complex demerger of Jubilant Life Sciences into Jubilant Pharmova and Jubilant Ingrevia to sharpen focus and unlock value.

🎯 Motivation●●●●●

As part of the Bhartia family, he manages the multi-generational Jubilant Bhartia Group with a clear focus on long-term family stewardship and succession.

👥 People●●●○○

The group's culture is characterized by long-term retention of senior leadership and a consensus-driven management style typical of family-run conglomerates.

📈 Growth●●●●○

Jubilant Pharmova's growth strategy has been heavily focused on expanding internal manufacturing capacities and operational efficiencies in the specialty pharma space.

💡 Innovation●●●●○

The company focuses on scaling complex generic formulations and specialty pharmaceutical products where execution and regulatory compliance are the primary competitive levers.

🏃 Pace●●●●○

As a manufacturer in the highly regulated pharmaceutical space, the company follows a methodical, process-driven operational rhythm focused on long-term supply chain stability.

🌱 Purpose●●●○○

The company operates primarily as a contract manufacturer and generic player where ESG initiatives are largely driven by regulatory compliance and operational necessity rather than a mission-led identity.

🏷️ Brand●●●●○

The company's market reputation is built on its technical capabilities in complex manufacturing, radiopharmaceuticals, and allergy therapy products.

🤝 Customer●●●●●

Jubilant Pharmo functions primarily as a B2B player providing contract manufacturing services and specialty products to global pharmaceutical companies.

💼 Employer●●●○○

The company is perceived as a stable, legacy-driven industrial employer within the pharmaceutical manufacturing sector rather than a high-growth startup or a talent-magnet consultancy.

📋 Mandate

Requires urgent deleveraging and asset optimization to stabilize the balance sheet and improve operating margins.

🏢 Culture●●●○○

Part of a large, long-standing conglomerate; culture reflects established formal structures and complex manufacturing processes.